Highlander Capital Management, LLC Dexcom Inc Transaction History

Highlander Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $13,597 - $26,577	200 Added 200.0%	300 $22,000
Q1 2022 May 09, 2022	BUY	$94.08 - $130.2 $9,408 - $13,019	100 New	100 $51,000
Q1 2021 May 14, 2021	SELL	$84.79 - $104.74 $8,479 - $10,474	-100 Closed	0 $0
Q3 2020 Nov 17, 2020	BUY	$95.51 - $112.95 $9,551 - $11,295	100 New	100 $41,000
Q2 2020 Aug 17, 2020	SELL	$62.68 - $105.34 $12,536 - $21,068	-200 Closed	0 $0
Q1 2020 May 27, 2020	BUY	$47.79 - $75.63 $9,558 - $15,126	200 New	200 $54,000

1,079

351M

8.45M

5.75M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $34.5B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Highlander Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Highlander Capital Management, LLC with notifications on news.